Nika Pharmaceuticals, Inc (NIKA) Change in Cash (2021 - 2023)

Nika Pharmaceuticals (NIKA) has 3 years of Change in Cash data on file, last reported at $8686.0 in Q4 2023.

• Quarterly Change in Cash rose 384.79% year-over-year to $8686.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $18732.0 (up 3928.39% YoY) and the FY2023 annual result came in at $18732.0, up 3928.39% from the prior year.
• Change in Cash climbed to $8686.0 in Q4 2023, from -$143.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $8686.0 in Q4 2023 to a low of -$4631.0 in Q3 2022.
• A 3-year average of $1498.8 and a median of -$198.5 in 2021 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash plunged 455.96% — and 2023, when it surged 1237.66%.
• Tracing NIKA's Change in Cash over 3 years: stood at -$1300.0 in 2021, then plunged by 134.62% to -$3050.0 in 2022, then soared by 384.79% to $8686.0 in 2023.
• The last three Change in Cash figures came in at $8686.0 (Q4 2023), -$143.0 (Q3 2023), and $6594.0 (Q2 2023), per Business Quant data.